|
全民健康保險藥品給付規定 / 健保碼及健保價 |
|
See related Human Albumin 20% inj[血清蛋白 注射劑] information |
|
|
|
製造商 |
CSL Behring |
|
代理/經銷商 |
Giraffes |
|
成份 |
Human albumin |
|
適應症 |
Albumin deficiency, compensation of oncotic deficiencies, vol replacement & plasma exchange. |
|
用量 |
Individualised dosage. |
|
美國食品藥物管理局之懷孕等級 |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
禁忌 |
Conditions in which hypervolaemia & its consequences or hemodilution could represent a special risk of the patient. |
|
不良反應 |
Increase or decrease in BP &/or heart rate, nausea & vomiting.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Human Albumin 20% 注射劑 |
|
Human Albumin 20% 20 % x 50 mL |
|
|
|
Manufacturer: |
CSL Behring |
|
Distributor: |
Giraffes
|
|
|
|
